decisionhealth Newsletters, Coder Pink Sheets - 2009 Issue 7 (July)
Breathing treatment meds still reimbursed
Subscribe or sign in to view the full article.
Article Overview
This article covers a Medicare update affecting office-based breathing treatment medications and the associated HCPCS billing approach. It is relevant to coders and billing staff working with respiratory therapy drugs, Medicare Part B payment methodology, and recent changes to how these services were reimbursed and reported.
Why This Topic Matters
It helps practices determine whether claims for commonly used inhalation drugs remain payable under Medicare and understand the broader coding changes that affected these medications over time.
Article Sections
-
Medicare reimbursement update
Overview of the payment update affecting office-supplied breathing treatment medications and how Medicare handled reimbursement for these claims.
-
Background on code changes
Summary of the prior coding changes and the timeline of Medicare revisions affecting these inhalation drug claims.
-
Codes used for dates of service on or after April 1, 2008
Identification of the relevant HCPCS identifiers tied to the revised reporting period.
What You Will Learn
- How the article frames Medicare reimbursement for office-administered breathing treatment medications
- What broader HCPCS billing changes affected these inhalation drugs
- Which types of Medicare payment methodology are discussed
- How the article situates the update within prior years of coding revisions
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Pulmonary and primary care practices
- Medicare billing specialists
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com